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Abstract
Dendritic cells (DC) constitute a heterogeneous leukocyte
population having in common a unique capacity to
induce primary T cell responses and are therefore most
attractive candidates for immunomodulatory strategies.
Two populations of blood DC (CD11c+ CD123dim and
CD11c– CD123high) have been defined so far. However,
their direct isolation for experimental purposes is ham-
pered by their low frequency and by the lack of selective
markers allowing large scale purification from blood.
Here we describe the monoclonal antibody (mAb) M-
DC8, which was generated by immunizing mice with
highly enriched blood DC. This mAb specifically reacts
with 0.2–1% of blood leukocytes and enables their direct
isolation by a one-step immunomagnetic procedure
from fresh mononuclear cells. These cells can be differ-
entiated from T cells, B cells, NK cells and monocytes
using lineage-specific antibodies. M-DC8+ cells express
HLA class II molecules, CD33 and low levels of the costi-
mulatory molecules CD86 and CD40. Upon in vitro cul-
ture M-DC8+ cells spontaneously mature into cells with
the phenotype of highly stimulatory cells as documented
by the upregulation of HLA-DR, CD86 and CD40; in paral-
lel CD80 expression is induced. M-DC8+ cells display an
outstanding capacity to present antigen. In particular,
they proved to be excellent stimulators of autologous
mixed leukocyte reaction and to activate T cells against
primary antigens such as keyhole limpet hemocyanin.
Furthermore, they induce differentiation of purified allo-
geneic cytotoxic T cells into alloantigen-specific cyto-
toxic effector cells. While the phenotypical analysis re-
veals similarities with the two known blood DC popula-
tions, the characteristic expression of FcÁRIII (CD16) and
the M-DC8 antigen clearly defines them as a novel popu-
lation of blood DC. The mAb M-DC8 might thus be a valu-
able tool to determine circulating DC for diagnostic pur-
poses and to isolate these cells for studies of antigen-
specific T cell priming.
Copyright © 2000 S. Karger AG, Basel
Introduction
Dendritic cells (DC) represent a unique cell population
linking the innate immune system with the adaptive, spe-
cific immune system. In particular they are capable of
activating primary antigen-specific T cell responses and
control their differentiation into Th1 and Th2 cells. Con-
ventional strategies such as depletion of lineage marker-
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positive cells and subsequent isolation of MHC class II-
expressing cells led to the definition of two major popula-
tions of DC regarded as a myeloid and lymphoid lineage
[1]. Phenotypically they are distinguished by the recipro-
cal expression of CD11c and CD123. Based on their dif-
ferential capacity as mature cells to induce Th1 and Th2
cells, the myeloid DC lineage was designated as DC1
(CD11c+ CD123low) and the lymphoid lineage as DC2
(CD11c– CD123high) [2]. However, when using freshly
isolated DC this effect could not be observed [3]. Despite
many attempts no specific surface molecules have thus far
been characterized, which could serve as a handle to iso-
late these DC subsets.
We succeeded in generating a novel mAb M-DC8,
which turned out to be a selective marker for 0.2–1% of
blood leukocytes. This small cell population shows char-
acteristic morphologic and functional features of DC and
can be directly isolated from fresh PBMC with the help of
the mAb M-DC8. M-DC8+ cells express CD16 not pre-
viously described for DC [1]. This finding, together with
the negative M-DC8 staining of DC1 and DC2 defines
M-DC8+ cells as a new subpopulation of blood DC.
Methods
Cell Culture
Cells were cultured in RPMI 1640 containing 2 mM L-glutamine,
1% nonessential amino acids (Biochrom, Berlin, Germany), 100 U/
ml penicillin, 100 Ìg/ml streptomycin (Gibco, Eggenstein, Germany)
and 10% human AB serum (c.c.pro, Neustadt, Germany).
Isolation of Cells
Human PBMC were isolated from buffy coat preparations by
Ficoll-Hypaque (Pharmacia, Freiburg, Germany) density centrifuga-
tion. M-DC8+ cells were obtained by incubating PBMC with M-DC8
hybridoma supernatant, washed with PBS and labeled with rat anti-
mouse IgM microbeads (Miltenyi Biotec, Bergisch-Gladbach, Ger-
many). After washing labeled M-DC8+ cells were purified by two
rounds of magnetic cell sorting using an LS and RS separation col-
umn. Using the nonmagnetic cell preparation monocytes were iso-
lated with the aid of anti-CD14 microbeads. T cells were isolated by
rosetting with sheep red blood cells treated with aminoethyl isothiu-
ronium bromide (Sigma, Deisenhofen, Germany). From this popula-
tion CD8+ T cells 198% purity were prepared by depleting CD4+
cells as rosettes with bovine red blood cells coated with the CD4 mAb
M-T310.
Flow-Cytometric Analysis
For three-color fluorescence analysis of M-DC8+ cells, blood cells
were incubated with undiluted M-DC8 hybridoma supernatant fol-
lowed by anti FITC-conjugated goat F(ab))2 anti-mouse IgM (Coul-
ter-Immunotec, Hamburg, Germany). After washing with PBS 0.1%
NaN3 cells were incubated with mAb specific for HLA-DR, CD3,
CD14, CD16, or CD19 (all from Pharmingen, Hamburg, Germany)
followed by lysis of erythrocytes.
T Cell Activation
Graded numbers of purified of APC were cocultured with puri-
fied T lymphocytes (1 ! 105) for 7 days in 0.2 ml medium in round-
bottomed microtiter plates (Corning, New York, N.Y., USA). Prolif-
eration of T cells was determined during the last 15 h by uptake of
[3H]thymidine (2 ÌCi/well; NEN, Cologne, Germany). Keyhole lim-
pet hemocyanin (KLH) was added at a concentration of 1 Ìg/ml.
Alloantigen-specific CTL were induced by coculture of purified
CD8+ T cells with allogeneic APC. After 7 days cells were harvested
and tested for CTL activity against 51Cr-labeled PHA blast of stimu-
lator origin.
Cytochemistry
·-Naphthyl acetate esterase (ANAE) activity was revealed by
incubation with p-rosaniline and naphthol AS-D chloroacetate sup-
plied in a test kit (Sigma). Mayer’s hemalum was used for counter-
staining. Benzidine-identified myeloperoxidase (MPO) activity and
Giemsa stain were used to identify cell nuclei.
Results
Phenotype of M-DC8+ Cells
Mice were immunized with T and B cell-depleted
HLA-DR+ PBMC. The hybridoma M-DC8 (isotype IgM)
was selected out of more than 6 ! 103 hybridoma super-
natants due to its staining of a HLA-DR+ cell population
accounting for 0.2–1% of total blood leukocytes (fig. 1a,
b) [4]. M-DC8+ cells can be clearly differentiated from
T cells, B cells, monocytes, NK cells and granulocytes by
their characteristic size and granularity and particularly
by using mAb specific for HLA-DR, CD3, CD14 and
CD19 (fig. 1a, b). Interestingly, M-DC8+ cells express
FcÁRIII (CD16) (fig. 1b), which is rapidly downregulated
upon culture (not shown). Previously defined populations
of blood DC are visualized by gating on HLA-DR+ cells
negative for CD16, CD3, CD14 and CD19 (upper left
quadrant of fig. 1c) which show no M-DC8 staining
(fig. 1d).
Stimulation of T Cells
In order to investigate the capacity of M-DC8+ cells to
promote the proliferation of T cells it was necessary to
isolate these cells at high purity. Given the specificity of
the mAb M-DC8 and its high avidity binding due to the
IgM isotype, we chose a direct isolation method from
PBMC employing an immunomagnetic separation (Mil-
tenyi) yielding 197% pure M-DC8+ cells [4].
As shown in figure 1e, M-DC8+ cells but not mono-
cytes induced a significant proliferation of autologous T
cells, a function ascribed to DC. Provided that DC are
best characterized by their unique capacity to prime anti-
gen-specific T cell responses, we investigated the induc-
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Fig. 1. Flow-cytometric analysis of human peripheral blood leuko-
cytes using the mAb M-DC8 and stimulation of T cell responses by
M-DC8+ cells [4]. In b gating was done on M-DC8+ cells revealed in
a and in d gating was done on previously identified DC depicted in
the upper left quadrant of c. T cell stimulation was done (e, f, g)
using M-DC8+ cells (P) or CD14+ monocytes ([) as APC. Prolifera-
tion of autologous T cells in the absence (e) or presence of KLH (f)
was determined by 15 h [3H]thymidine uptake. Values of T cell pro-
liferation in the absence of antigen were substracted from the total
cpm (f). Alloantigen-specific cytotoxic T cells (g) were induced cocul-
turing CD8+ T cells with allogeneic APC. Cytotoxicity of T lympho-
cytes was tested against 51Cr-labeled stimulator-type PHA blasts.
Reproduced with permission [4].
tion of a T cell response specific for the neoantigen KLH.
In these assays M-DC8+ cells in contrast to CD14+ mono-
cytes were efficient inducers of a KLH-specific T cell
response (fig. 1f). Furthermore, we tested the capacity of
M-DC8+ cells to prime CD8+ cytotoxic T cells in vitro
(fig. 1d). In these assays, M-DC8+ cells or monocytes were
cocultured with purified allogeneic CD8+ T cells. After 7
days cytotoxicity was determined using 51Cr-labeled sti-
mulator-type PHA blasts as target cells. As shown in fig-
ure 1g, M-DC8+ cells were by far more efficient than
monocytes in activating alloantigen-specific cytotoxic ef-
fector cells.
Enzyme Cytochemistry
Cytospins of freshly isolated M-DC8+ cells and mono-
cytes were used to demonstrate ANAE and MPO. While
CD14+ monocytes, as also known for macrophages,
showed an intense ANAE reaction and were faintly posi-
tive for MPO, M-DC8+ cells as attributed to DC were
negative for both enzyme activities (fig. 2).
Discussion
Here we report on a new population of DC defined by
the novel mAb M-DC8. The mAb was obtained by immu-
nizing mice with mononuclear cells highly enriched for
DC. It specifically reacted with a small cellular leukocyte
subset comprising 0.2–1% of total blood leukocytes which
was HLA-DR+ and lacked expression of common lineage-
specific markers. Supported by the characteristic light
scatter profile, the mAb M-DC8 was considered as a good
candidate marker for human blood DC.
Two human blood DC populations have been defined
so far: DC1 (CD11c+ CD123low) are of myeloid origin,
representing Langerhans cells and interstitial DC, where-
as DC2 (CD11c– CD123high) previously described as
plasmacytoid T cells or plasmacytoid monocytes are iden-
tical to the natural interferon-·-producing cells repre-
senting lymphoid DC [3]. Based on the expression of
CD13, CD33 (not shown) M-DC8+ cells seemed to be
more closely linked to the myeloid DC population. How-
ever, several lines of evidence suggest that the mAb
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Fig. 2. Enzyme cytochemistry. Cytospins of M-DC8+ cells (a, c)
and monocytes (b, d) were tested for ANAE (a, b) or MPO activity
(c, d). Reproduced with permission [4].
M-DC8 is a marker specific for a novel population of
blood DC: (1) the mAb M-DC8 does not stain DC1 or
DC2; (2) M-DC8+ cells express CD16, and (3) monocyte-
derived DC are negative for M-DC8 staining (not shown).
Concerning the origin of M-DC8+ cells it is of note that
small numbers of M-DC8+ cells develop in vitro from
CD34+ stem cell cultures supplied with GM-CSF and
TNF-· (unpubl. observation).
The mAb M-DC8 seems to be unique among the
increasing number of DC-related or DC-specific reagents.
In contrast to CD83 and CMRF-44, both induced upon
culture and fascin/p55, which is confined to the cyto-
plasm, the M-DC8-Ag is already expressed on circulating
blood cells, enabling the direct isolation of this cell popu-
lation without additional in vitro manipulation. Further-
more, the M-DC8 antigen is not induced on other PBMC
during in vitro culture, making it possible to follow M-
DC8+ cells.
In a variable percentage (25% donor 1 and 50% do-
nor 2) M-DC8+ cells are found among a cell population
regarded as macrophage-like cells which may be best char-
acterized by their expression of CD16 and HLA-DR [5].
However, the absence of ANAE and MPO activity and
the lack of M-DC8 expression by macrophages clearly dis-
criminate M-DC8+ cells from macrophages.
M-DC8+ cells displayed an outstanding antigen-pre-
senting capacity. In contrast to monocytes, M-DC8+ cells
efficiently stimulated the proliferation of autologous T
cells, and furthermore, they induced a marked T cell
response specific for the neoantigen KLH. In addition,
a coculture of purified CD8+ T cells with allogeneic
M-DC8+ cells led to the generation of alloantigen-specific
cytotoxic T cells independent of the help provided by
CD4+ T cells. Taken together, M-DC8+ cells represent a
distinct population of human blood DC which has pre-
viously not been recognized. Based on the data obtained
so far M-DC8+ cells seem to be more closely related to
DC1 rather than to DC2. However, M-DC8+ cells can be
distinguished from other professional APC by the high
density expression of FcÁRIII which may equip these cells
with particular functional features, e.g. efficient uptake of
antigens complexed with antibodies. Identification of DC
subpopulations, definition of their activation require-
ments and their capacity to program Th1 and Th2 cells
may expand our knowledge of the regulation of specific
immune responses.
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